{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:30:05Z","timestamp":1790901005851,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.dsx.2020.04.049","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T17:39:18Z","timestamp":1588786758000},"page":"513-517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":221,"title":["COVID-19 and diabetes mellitus: An unholy interaction of two pandemics"],"prefix":"10.1016","volume":"14","author":[{"given":"Rimesh","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K.","family":"Bhadada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2020.04.049_bib2","author":"Omer"},{"key":"10.1016\/j.dsx.2020.04.049_bib3","first-page":"108132","article-title":"COVID-19 and non-communicable diseases","volume":"162","author":"Pal","year":"2020","journal-title":"Postgrad Med"},{"key":"10.1016\/j.dsx.2020.04.049_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108132","article-title":"COVID-19, diabetes mellitus and ACE2: the conundrum","author":"Pal","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.dsx.2020.04.049_bib5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.dsx.2020.04.004","article-title":"Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2020.04.049_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.dsx.2020.04.018","article-title":"Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia \u2013 a systematic review, meta-analysis, and meta-regression","volume":"14","author":"Huang","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2020.04.049_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese center for disease control and prevention","author":"Wu","year":"2020","journal-title":"JAMA [Internet]"},{"key":"10.1016\/j.dsx.2020.04.049_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4683","article-title":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","author":"Onder","year":"2020","journal-title":"JAMA [Internet]"},{"key":"10.1016\/j.dsx.2020.04.049_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s40618-020-01236-2","article-title":"Prevalence and impact of diabetes among people infected with SARS-CoV-2","author":"Fadini","year":"2020","journal-title":"J\u00a0Endocrinol Invest [Internet]"},{"key":"10.1016\/j.dsx.2020.04.049_bib10","doi-asserted-by":"crossref","first-page":"2000547","DOI":"10.1183\/13993003.00547-2020","article-title":"Comorbidity and its impact on 1590 patients with covid-19 in China: a nationwide analysis","author":"Guan","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.dsx.2020.04.049_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.amjms.2015.11.011","article-title":"The effect of short-term hyperglycemia on the innate immune system","volume":"351","author":"Jafar","year":"2016","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.dsx.2020.04.049_bib13","doi-asserted-by":"crossref","first-page":"e3319","DOI":"10.1002\/dmrr.3319","article-title":"Diabetes is a risk factor for the progression and prognosis of COVID-19","author":"Guo","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.dsx.2020.04.049_bib14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/1566524053766059","article-title":"Type 2 diabetes: an atherothrombotic syndrome","volume":"5","author":"Dunn","year":"2005","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.dsx.2020.04.049_bib15","doi-asserted-by":"crossref","first-page":"108142","DOI":"10.1016\/j.diabres.2020.108142","article-title":"COVID-19 and diabetes: knowledge in progress","volume":"162","author":"Hussain","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.dsx.2020.04.049_bib16","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1038\/ncomms4594","article-title":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections","volume":"5","author":"Zou","year":"2014","journal-title":"Nat Commun [Internet]"},{"key":"10.1016\/j.dsx.2020.04.049_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/256294","article-title":"Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease","volume":"2012","author":"Tikellis","year":"2012","journal-title":"Int J Pept"},{"key":"10.1016\/j.dsx.2020.04.049_bib18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.dsx.2020.04.019","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic","volume":"14","author":"Cure","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2020.04.049_bib19","author":"Wenzhong"},{"key":"10.1016\/j.dsx.2020.04.049_bib20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1464-5491.2006.01861.x","article-title":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS","volume":"23","author":"Yang","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/j.dsx.2020.04.049_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00592-009-0109-4","article-title":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes","volume":"47","author":"Yang","year":"2010","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.dsx.2020.04.049_bib22","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/path.1560","article-title":"Organ distribution of severe acute respiratory syndrome(SARS) associated coronavirus(SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways","volume":"203","author":"Ding","year":"2004","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.dsx.2020.04.049_bib23","doi-asserted-by":"crossref","first-page":"e13034","DOI":"10.1111\/obr.13034","article-title":"Risk of COVID-19 for patients with obesity","volume":"21","author":"Kassir","year":"2020","journal-title":"Obes Rev [Internet]"},{"key":"10.1016\/j.dsx.2020.04.049_bib24","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/pmic.200500638","article-title":"Inflammation inhibitors were remarkably up-regulated in plasma of severe acute respiratory syndrome patients at progressive phase","volume":"6","author":"Wan","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.dsx.2020.04.049_bib25","doi-asserted-by":"crossref","first-page":"488","DOI":"10.12998\/wjcc.v2.i10.488","article-title":"Diabetes mellitus and electrolyte disorders","volume":"2","author":"Liamis","year":"2014","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.dsx.2020.04.049_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/oby.22838","article-title":"Considerations for obesity, vitamin D, and physical activity amidst the COVID-19 pandemic","author":"Carter","year":"2020","journal-title":"Obesity [Internet]"},{"key":"10.1016\/j.dsx.2020.04.049_bib27","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3390\/nu11040794","article-title":"Analysis of association between vitamin D deficiency and insulin resistance","volume":"11","author":"Szymczak-Pajor","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.dsx.2020.04.049_bib28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/s40064-015-1218-x","article-title":"Iatrogenic Cushing syndrome and adrenal insufficiency during concomitant therapy with ritonavir and fluticasone","volume":"4","author":"Epperla","year":"2015","journal-title":"SpringerPlus [Internet]"},{"key":"10.1016\/j.dsx.2020.04.049_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104791","article-title":"Type 1 interferons as a potential treatment against COVID-19","volume":"178","author":"Sallard","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.dsx.2020.04.049_bib30","doi-asserted-by":"crossref","DOI":"10.2337\/dc10-2274","article-title":"Type 1 diabetes and interferon therapy: a nationwide survey in Japan","volume":"34","author":"Nakamura","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2020.04.049_bib31","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.dsx.2020.04.049_bib32","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/cid\/cit439","article-title":"Risk of severe dysglycemia among diabetic patients receiving levofloxacin, ciprofloxacin, or moxifloxacin in taiwan","volume":"57","author":"Chou","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.dsx.2020.04.049_bib33","doi-asserted-by":"crossref","first-page":"154216","DOI":"10.1016\/j.metabol.2020.154216","article-title":"Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China","volume":"107","author":"Zhou","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.dsx.2020.04.049_bib34","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1210\/jc.2018-01168","article-title":"Effect of hypoglycemia on inflammatory responses and the response to low-dose endotoxemia in humans","volume":"104","author":"Iqbal","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.dsx.2020.04.049_bib35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.dsx.2020.03.002","article-title":"Clinical considerations for patients with diabetes in times of COVID-19 epidemic","volume":"14","author":"Gupta","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2020.04.049_bib36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.dsx.2020.04.013","article-title":"Diabetes self-management amid COVID-19 pandemic","volume":"14","author":"Banerjee","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev [Internet]"},{"key":"10.1016\/j.dsx.2020.04.049_bib37","author":"Xue"},{"key":"10.1016\/j.dsx.2020.04.049_bib38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.dsx.2020.04.001","article-title":"Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: guidelines for physicians","volume":"14","author":"Ghosh","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.dsx.2020.04.049_bib39","doi-asserted-by":"crossref","first-page":"108146","DOI":"10.1016\/j.diabres.2020.108146","article-title":"Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?","volume":"163","author":"Pal","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.dsx.2020.04.049_bib40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.dsx.2020.03.011","article-title":"Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: a systematic search and a narrative review with a special reference to India and other developing countries","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2020.04.049_bib41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/2042018814547204","article-title":"A\u00a0favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role","volume":"5","author":"Hage","year":"2014","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.dsx.2020.04.049_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196368","article-title":"Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study","volume":"13","author":"Otsuka","year":"2018","journal-title":"PloS One"},{"issue":"18","key":"10.1016\/j.dsx.2020.04.049_bib43","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.3390\/ijms20184633","article-title":"Effects of tocilizumab, an anti-interleukin-6 receptor antibody, on serum lipid and adipokine levels in patients with rheumatoid arthritis","volume":"20","author":"Hoffman","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dsx.2020.04.049_bib44","first-page":"1039","article-title":"Camostat mesilate decreases the blood glucose level in insulin-treated diabetic patients","volume":"30","author":"Mori","year":"1987","journal-title":"J\u00a0Jpn Diabetes Soc"},{"key":"10.1016\/j.dsx.2020.04.049_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","author":"Wang","year":"2020","journal-title":"The Lancet [Internet]"},{"key":"10.1016\/j.dsx.2020.04.049_bib46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jiu396","article-title":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis","volume":"211","author":"Mair-Jenkins","year":"2015","journal-title":"J\u00a0Infect Dis"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402120301144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402120301144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:13:42Z","timestamp":1761729222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402120301144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1871402120301144"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2020.04.049","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 and diabetes mellitus: An unholy interaction of two pandemics","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2020.04.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd on behalf of Diabetes India.","name":"copyright","label":"Copyright"}]}}